ARMOUR Residential REIT (NYSE:ARR) Stock Rating Lowered by StockNews.com

ARMOUR Residential REIT (NYSE:ARR) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday.

Several other research firms have also recently weighed in on ARR. BTIG Research began coverage on shares of ARMOUR Residential REIT in a report on Monday, February 10th. They issued a “neutral” rating on the stock. JMP Securities reiterated a “market perform” rating on shares of ARMOUR Residential REIT in a report on Thursday, January 23rd. Finally, B. Riley upgraded shares of ARMOUR Residential REIT to a “hold” rating in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $20.50.

ARMOUR Residential REIT Stock Performance

Shares of ARMOUR Residential REIT stock opened at $19.19 on Friday. ARMOUR Residential REIT has a 52-week low of $17.35 and a 52-week high of $21.93. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of 8.13 and a beta of 1.48. The company’s 50 day moving average price is $18.81 and its 200-day moving average price is $19.43.

Insider Transactions at ARMOUR Residential REIT

In other ARMOUR Residential REIT news, Director Stewart J. Paperin sold 24,852 shares of the business’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $18.78, for a total value of $466,720.56. Following the completion of the transaction, the director now owns 363 shares of the company’s stock, valued at approximately $6,817.14. The trade was a 98.56 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert C. Hain sold 2,500 shares of the business’s stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $18.07, for a total value of $45,175.00. Following the completion of the transaction, the director now directly owns 6,793 shares of the company’s stock, valued at approximately $122,749.51. This trade represents a 26.90 % decrease in their position. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Hedge Funds Weigh In On ARMOUR Residential REIT

A number of hedge funds have recently bought and sold shares of ARR. Signaturefd LLC raised its position in ARMOUR Residential REIT by 67.8% in the 3rd quarter. Signaturefd LLC now owns 1,374 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 555 shares during the last quarter. Private Trust Co. NA purchased a new position in ARMOUR Residential REIT in the 4th quarter worth about $28,000. Sterling Capital Management LLC raised its position in ARMOUR Residential REIT by 927.9% in the 4th quarter. Sterling Capital Management LLC now owns 1,768 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 1,596 shares during the last quarter. Russell Investments Group Ltd. raised its position in ARMOUR Residential REIT by 35.2% in the 4th quarter. Russell Investments Group Ltd. now owns 2,695 shares of the real estate investment trust’s stock worth $51,000 after buying an additional 702 shares during the last quarter. Finally, McIlrath & Eck LLC bought a new stake in shares of ARMOUR Residential REIT during the 3rd quarter valued at about $61,000. Hedge funds and other institutional investors own 54.17% of the company’s stock.

About ARMOUR Residential REIT

ARMOUR Residential REIT, Inc invests in residential mortgage-backed securities (MBS) in the United States. Its securities portfolio primarily consists of the United States Government-sponsored entity's (GSE) and the Government National Mortgage Administration's issued or guaranteed securities backed by fixed rate, hybrid adjustable rate, and adjustable-rate home loans; and unsecured notes and bonds issued by the GSE and the United States treasuries, as well as money market instruments.